Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
REPOMIA
- Development stage
- Unknown
- Lead developer
- Biokindle Lifesciences
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intravenous
01
Overview
REPOMIA is a recombinant human erythropoietin alpha (rHuEPO) developed by Biokindle Lifesciences. It contains epoetin alfa as the active ingredient and functions as an erythropoiesis-stimulating agent (ESA). By binding to the erythropoietin receptor on erythroid progenitor cells in the bone marrow, it stimulates their division and differentiation into mature red blood cells. REPOMIA is indicated for the treatment of anemia associated with chronic kidney disease (CKD) in patients both on and not on dialysis, as well as anemia resulting from zidovudine therapy in HIV-infected patients and chemotherapy in cancer patients. It is supplied as a solution for injection in pre-filled syringes.
- Brand names
- REPOMIA
- Other names
- epoetin alfarecombinant human erythropoietin alpharHuEPO
02
Targets
Erythropoietin Receptor
Beyond the preview
Go deeper on REPOMIA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on REPOMIA.